California Public Employees Retirement System’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

California Public Employees Retirement System’s Portfolio CADX Stock Details CADX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-107,500	Closed	-$981K	–	4026
2013 Q4	$981K	Sell	107,500 -2,425	-2%	-$17.5K	﹤0.01%	2577
2013 Q3	$694K	Buy	109,925 +21,800	+25%	+$139K	﹤0.01%	2597
2013 Q2	$601K	Buy	+88,125	New	+$614K	﹤0.01%	2573

Other funds holding CADX

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

California Public Employees Retirement System's CADX Position: Q1 2014 in Review

California Public Employees Retirement System sold out of CADENCE PHARMACEUTICALS, INC COM STK (CADX) in Q1 2014, closing a stake of 107,500 shares — an estimated $981K sold.

California Public Employees Retirement System first reported a position in CADX in Q2 2013 and held it in 3 quarters. The position peaked at $981K in Q4 2013. 3 funds tracked by Wall St. Rank hold CADX as of Q1 2014.

California Public Employees Retirement System reported no remaining CADENCE PHARMACEUTICALS, INC COM STK position as of Q1 2014 after selling out during the quarter.
California Public Employees Retirement System sold 107,500 CADENCE PHARMACEUTICALS, INC COM STK shares in Q1 2014, an estimated $981K.
California Public Employees Retirement System first reported a position in CADENCE PHARMACEUTICALS, INC COM STK in Q2 2013 and held it in 3 quarters.
California Public Employees Retirement System's CADENCE PHARMACEUTICALS, INC COM STK position peaked at $981K in Q4 2013.
3 funds tracked by Wall St. Rank held CADENCE PHARMACEUTICALS, INC COM STK as of Q1 2014.

Based on California Public Employees Retirement System's 13F filing for Q1 2014, filed 18 Apr 2014.